People ages 65 and older who received Pfizer’s updated (bivalent) COVID-19 booster shot may be at increased risk of stroke, according to an announcement made by the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration.1 The joint statement warns that the CDC’s Vaccine Safety Datalink (VSD), which uses near real-time… Read More: Stroke Risk With Pfizer Shot Announced »
The Coronavirus Outbreak Covid-19 Updates Coronavirus Map and Cases Delta Variant Pandemic Relief Programs Ending What is HIPAA? Advertisement Continue reading the main story Supported by Continue reading the main story Israeli Data Suggests Possible Waning in Effectiveness of Pfizer Vaccine The new numbers still show overwhelmingly strong protection against severe disease but diminished effectiveness against… Read More: Israeli Data Suggests Possible Waning in Effectiveness of Pfizer Vaccine »
Breadcrumb Trail Links News Health Canada While health authorities are reassuring Canadians that it’s safe to mix COVID-19 vaccines doses, some appear to be rejecting Moderna for Pfizer Author of the article: Sharon Kirkey Publishing date: Jun 24, 2021 • June 24, 2021 • 5 minute read • 126 Comments “There may be some brand… Read More: Pfizer is not superior to Moderna and it’s ‘perfectly okay’… »
Boris Johnson warns Pfizer jab ‘WON’T deliver knock-out blow’ needed to end lockdown as 50 rebel Tory MPs say PM must not use vaccine as excuse to keep England closed for even longer Fears that Britons could face more confusion when the current lockdown comes to an end on December 2 Government is looking again… Read More: Coronavirus: Boris Johnson warns Pfizer jab WON’T end lockdown »